Antiemesis Panel - Disclosures
Panel Member
|
Rajiv Agarwal MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Sidharth Anand MD, MBA |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nusayba Bagegni MD |
Grant/Research Support
|
| Ambrx, Inc | AstraZeneca Pharmaceuticals LP | Atossa Therapeutics, Inc | Biovica International AB | Daiichi- Sankyo Co. | Novartis Pharmaceuticals Corporation | Pfizer Inc. | Sarah Cannon Development Innovations, LLC | SeaGen | Sermonix Pharmaceuticals, Inc | XCOVERY |
Date Completed
|
07/30/2024 |
Panel Member
|
Sally Barbour PharmD, BCOP, CPP, FHOPA |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jill Beck MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Michael Berger PharmD, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Heather Bitar DO |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nicole Blankenhorn |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
George Brown MS, RPh, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Anthony Christensen PharmD, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Elizabeth Dow-Hillgartner PharmD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kevin Du MD, PhD, MSCI |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nakia Duncan PharmD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Sara Espinosa PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Christopher Fausel PharmD, MHA, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Eric Goodlev MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kristina Gregory MSN, RN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Cassia Griswold PharmD, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Laura Hall PharmD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kyle Herrmann BSN, RN, OCN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Erin Hesler |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Andrea Iannucci PharmD, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nusrat Jahan MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nicole Kaiser RPh, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ann Karosas RPh, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Emily Kathol PharmD, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Reginald King PharmD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Emily Konerman PharmD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Mark Kris MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Janine Martino PharmD, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Beth McCullough RN, BS, CMSRN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Christine McLaughlin |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jonathan Metts MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kimberly Noonan DNP, RN, ANP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Cindy O'Bryant PharmD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Aaron Oliver PharmD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Stacy Prelewicz PharmD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Grazyna Riebandt PharmD, BCOP |
Equity Interest/Stock Options
|
| Iovance pharmaceuticals |
Date Completed
|
06/10/2024 |
Panel Member
|
Jane Rogers PharmD, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Susan Scott MD |
Grant/Research Support
|
| Black Diamond Therapeutics | Bristol Myers Squibb | Janssen Pharmaceutica Products, LP |
Date Completed
|
02/27/2025 |
Panel Member
|
Bridget Scullion PharmD, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Laura Sedig MD, MSc |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Eve Segal PharmD, BCOP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Maria Silveira MD, MA, MPH |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Melanie Smith MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kelly Truby NP-C |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Suzanne Walker PhD, CRNP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |